Table 2.
Baseline characteristics and outcomes of intubated patients.
| Total (n = 580) | Without severe Bronchiectasis (n = 488) | Severe Bronchiectasis (n = 92) | P-value | |
|---|---|---|---|---|
| Age, years | 66.1 ± 13.9 | 66.4 ± 14.1 | 64.7 ± 13.0 | 0.267 |
| Sex, male | 383 (66.0) | 328 (67.2) | 55 (59.8) | 0.208 |
| BMI, kg/m2 | 22.0 ± 4.4 | 22.2 ± 4.5 | 20.7 ± 3.7 | 0.001 |
| APACHE II score | 27.6 ± 8.6 | 27.8 ± 8.6 | 26.8 ± 9.1 | 0.321 |
| SOFA score | 8.8 ± 3.9 | 9.0 ± 4.0 | 7.9 ± 3.2 | 0.006 |
| CCI score | 3.6 ± 2.5 | 3.6 ± 2.5 | 3.5 ± 2.7 | 0.666 |
| Asthma | 45 (7.1) | 35 (7.2) | 10 (10.9) | 0.316 |
| COPD | 83 (14.3) | 56 (11.5) | 27 (29.3) | < 0.001 |
| Bronchiectasis | 125 (21.6) | |||
| Severe bronchiectasis | 92 (15.9) | |||
| Septic shock | 435 (75.0) | 367 (75.2) | 68 (73.9) | 0.896 |
| CRRT | 179 (30.9) | 156 (32.0) | 23 (25.0) | 0.229 |
| Outcomes | ||||
| 28-day mortality | 192 (33.1) | 157 (32.2) | 35 (38.0) | 0.329 |
| ICU mortality | 190 (32.8) | 153 (31.4) | 37 (40.2) | 0.123 |
| In-hospital mortality | 292 (50.3) | 235 (48.2) | 57 (62.0) | 0.021 |
| ICU stay, day | 12 [6–21] | 11 [6–21] | 14 [8–24] | 0.056 |
| Hospital stay, day | 40 [20–74] | 40 [20–72] | 50 [25–108] | 0.055 |
Note: Data are presented as numbers (%), mean ± standard deviation, or median [interquartile range].
APACHE II Acute Physiology and Chronic Health Evaluation II, BMI body mass index, CCI Charlson comorbidity index, COPD chronic obstructive pulmonary disease, CRRT continuous renal replacement therapy, ICU intensive care unit, SOFA sequential organ failure assessment.